CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
A Roadmap for Reducing Pediatric Mental Health Boarding
Pediatric mental health boarding is a system challenge. States have the power to change it.
Oct. 19, 2026
Reducing Pediatric Mental Health Boarding and Extended Hospital Stays
Children deserve timely access to mental health care. This policy framework offers solutions.
Oct. 13, 2026
CHA Submits Comments in Response to Medicaid Provider Tax Proposed Rule
The comments urge CMS to preserve the state financing flexibility necessary to ensure children nationwide continue to have access to high quality, specialized pediatric care.
Oct. 12, 2026
